Drug Shortage Report for ADENOSINE INJECTION
| Report ID | 159832 |
| Drug Identification Number | 02457474 |
| Brand name | ADENOSINE INJECTION |
| Common or Proper name | ADENOSINE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ADENOSINE |
| Strength(s) | 3MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2ML |
| ATC code | C01EB |
| ATC description | OTHER CARDIAC PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-02 |
| Estimated end date | Unknown |
| Actual end date | 2022-12-31 |
| Shortage status | Resolved |
| Updated date | 2023-01-02 |
| Company comments | Allocations for Adenosine Injection 3 mg/mL prefilled syringe 2 mL will be reducing from 100% demand of 2mL syringe plus 100% demand of 2mL vial to only cover 100% demand of 2mL syringe. Please note, our Adenosine Injection 3 mg/mL SD Vial 2ml is off backorder and available to all customers without restrictions. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-05-02 | English | Compare |
| v2 | 2022-05-02 | French | Compare |
| v3 | 2022-05-02 | French | Compare |
| v4 | 2022-05-02 | English | Compare |
| v5 | 2022-05-02 | French | Compare |
| v6 | 2022-05-03 | English | Compare |
| v7 | 2022-06-06 | English | Compare |
| v8 | 2022-06-06 | French | Compare |
| v9 | 2022-07-07 | English | Compare |
| v10 | 2022-07-07 | French | Compare |
| v11 | 2023-01-02 | English | Compare |
| v12 | 2023-01-02 | French | Compare |
Showing 1 to 12 of 12